Metaverse Surgical Simulation Platform
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jul 16, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of virtual reality (VR) technology to create a training platform for lung surgery. The goal is to help surgeons practice and rehearse complex procedures in a safe, simulated environment before performing the actual surgery. This innovation aims to enhance the safety and effectiveness of difficult surgeries, making them smoother for both patients and doctors.
To participate in the trial, you must be between the ages of 65 and 74 and have a high-resolution CT scan that can be used to create the VR simulation. The trial is currently recruiting participants, and your doctor will help determine if you are a suitable candidate. If you join, you can expect to engage with advanced VR technology that will allow surgeons to practice and prepare for real-life surgeries, ultimately aiming to improve patient outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Physicians assess suitable candidates.
- • 2. Consent to the use of their high-resolution computed tomography (CT) scan results as digital simulation material for the establishment of a virtual reality surgical platform.
- Exclusion Criteria:
- • 1. Those without high-resolution computed tomography (CT) scan results.
- • 2. Any conditions and circumstances that the trial principal investigator believes may affect the establishment of the trial platform.
- • 3. Those who have concerns about providing their own CT data.
- 4. (For trial user) The exclusion criteria are:
- • (1) Individuals under the age of 18 are excluded.
- • (2) Any condition or circumstance that the principal investigator deems may affect the establishment of the trial platform.
- • (3) Those who have concerns about providing their own data related to using the surgical simulation platform.
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Xu-Heng Chiang, MD
Principal Investigator
National Taiwan University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported